Effects of Neuromuscular Pelvic Realigning Exercises on Pelvic Floor Muscle Function in Continent SubjectS

Sponsor
University of North Georgia (Other)
Overall Status
Unknown status
CT.gov ID
NCT03975686
Collaborator
(none)
30
1
2
2.9
10.3

Study Details

Study Description

Brief Summary

The goal of this research study is to investigate the effect of a new neuromuscular approach for correcting pelvic alignment and improving pelvic floor muscle function. Investigators hypothesized that this approach would be significantly superior than no intervention to improve the ability of pelvic floor muscle contraction, measured by transabdominal sonography as bladder base elevation. Participants will be randomized to the intervention and control groups. while intervention group will receive five supervised sessions of pelvic realigning exercises, the control group will receive no intervention. Bladder base elevation will be measured as an indicator of pelvic floor muscle function, before and after one week intervention in both control and intervention groups.

Condition or Disease Intervention/Treatment Phase
  • Other: neuromuscual realigning exercise
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
30 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Effects of Neuromuscular Pelvic Realigning Exercises on Pelvic Floor Muscle Function in Continent Subjects: A Randomized Control Trial
Anticipated Study Start Date :
Jun 1, 2020
Anticipated Primary Completion Date :
Jul 30, 2020
Anticipated Study Completion Date :
Aug 29, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: intervention

Other: neuromuscual realigning exercise
neuromuscular realigning exercise

No Intervention: control

Outcome Measures

Primary Outcome Measures

  1. bladder base elevation [one week]

    the ability to contract pelvic floor muscle measured as bladder base elevation by transabdominal ultrasound

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 45 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:

Positive Ober's test

Exclusion Criteria:
  • pelvic/low back pain in previous 12 months

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of North Georgia Dahlonega Georgia United States 30533

Sponsors and Collaborators

  • University of North Georgia

Investigators

  • Study Director: Mahshid A Chehrehrazi, Student, University of North Georgia
  • Principal Investigator: Mohammad R Nourbakhsh, professor, University of North Georgia

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Mohammad(Reza) Nourbakhsh, Full Professor, University of North Georgia
ClinicalTrials.gov Identifier:
NCT03975686
Other Study ID Numbers:
  • UNorthGeorgia
First Posted:
Jun 5, 2019
Last Update Posted:
Mar 31, 2020
Last Verified:
Mar 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 31, 2020